Angina

Clinical Trial Finder

Many patients with angina are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial)

Conditions:   Stable Angina Pectoris;   Unstable Angina Pectoris
Intervention:   Device: Paclitaxel-Coated Balloon
Sponsor:   The People's Hospital of Liaoning Province
Not yet recruiting - verified May 2017

Stress CMR in Patients With Coronary Chronic Total Occlusions

Condition:   Coronary Chronic Total Occlusions
Intervention:   Procedure: PCI
Sponsor:   Ospedale San Donato
Not yet recruiting - verified May 2017

A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Condition:   Sickle Cell Disease
Interventions:   Drug: Ticagrelor granule;   Drug: Ticagrelor pediatric tablets;   Drug: Ticagrelor pediatric tablets suspended in water;   Drug: Ticagrelor immediate release (IR) tablets (Commercial tablet)
Sponsors:   AstraZeneca;   Parexel
Recruiting - verified May 2017

Optical Coherence Tomography in Acute Coronary Syndrome

Conditions:   Acute Coronary Syndrome;   STEMI - ST Elevation Myocardial Infarction;   NSTEMI - Non-ST Segment Elevation MI;   Atherosclerosis, Coronary
Intervention:  
Sponsors:   Charite University, Berlin, Germany;   Berlin Institut of Health (BIH), Germany
Recruiting - verified May 2017

Clinical Presentations Before AMI Onset and Coronary Atherosclerosis

Condition:   Acute Myocardial Infarction
Intervention:  
Sponsor:   Harbin Medical University
Completed - verified May 2017

Evaluation of Coronary Artery Plaque Volume Progression/Regression and Safety of Alirocumab in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia

Conditions:   Hypercholesterolemia;   Acute Coronary Syndrome
Interventions:   Drug: alirocumab SAR236553;   Drug: atorvastatin;   Drug: rosuvastatin;   Drug: fenofibrate;   Drug: bezafibrate;   Drug: ezetimibe;   Drug: antiplatelets;   Drug: anticoagulants
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Recruiting - verified May 2017

Use of Different Diagnostic Coronary Catheters Over the Radial Access - the UDDC - Radial Trial

Condition:   Stable Coronary Heart Disease
Interventions:   Device: One-catheter concept;   Device: Standard catheter
Sponsor:   Charite University, Berlin, Germany
Completed - verified May 2017

Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis

Conditions:   Coronary Artery Disease;   Acute Coronary Syndrome;   Myocardial Infarction;   Angina Pectoris
Intervention:   Device: Resolute Onyx
Sponsors:   Seoul National University Hospital;   Medtronic
Recruiting - verified May 2017

Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM)

Condition:   Coronary Heart Disease
Intervention:  
Sponsors:   Yonsei University;   Montreal Heart Institute;   Hospital da Luz, Portugal;   University of California, Los Angeles;   Centro Cardiologico Monzino;   University of British Columbia;   German Heart Institute;   National Institute of Cardiology, Laranjeiras, Brazil;   Weill Medical College of Cornell University;   Cedars-Sinai Medical Center
Active, not recruiting - verified May 2017

Integrated Primary Care for Diabetes and Cardiovascular Disease

Conditions:   Diabetes Mellitus;   Hypertension;   Heart Failure;   Ischemic Heart Disease;   Cerebrovascular Disease
Interventions:   Behavioral: Outreach education training;   Behavioral: No outreach education training
Sponsors:   University of Sao Paulo General Hospital;   University of Sao Paulo;   Santa Catarina Federal University;   University of Cape Town;   Federal University of Bahia;   Medical Research Council, South Africa;   University of East Anglia
Recruiting - verified January 2017

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes

Conditions:   Diabetes;   Diabetes Mellitus, Type 2
Interventions:   Drug: semaglutide;   Drug: placebo
Sponsor:   Novo Nordisk A/S
Recruiting - verified May 2017

Treadmill CV Safety Study

Condition:   Stable Angina
Interventions:   Drug: AMG 334;   Drug: Placebo
Sponsor:   Amgen
Completed - verified May 2017

Boston Scientific COMET Wire Validation Study

Condition:   Stable Angina
Interventions:   Device: Boston Scientific Pressure Wire;   Device: Validation of Boston Scientific pressure wire
Sponsors:   University Hospital Southampton NHS Foundation Trust;   Liverpool Heart and Chest Hospital NHS Foundation Trust;   Boston Scientific Corporation
Completed - verified May 2017

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus
Interventions:   Biological: Albiglutide 30 mg;   Biological: Albiglutide 50 mg;   Biological: Albiglutide matching placebo
Sponsors:   GlaxoSmithKline;   Duke Clinical Research Institute
Active, not recruiting - verified May 2017

RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsor:   AstraZeneca
Active, not recruiting - verified May 2017

Consistent CTO Trial

Condition:   Chronic Total Occlusion
Intervention:   Device: Percutaneous coronary intervention
Sponsors:   European Cardiovascular Research Center;   Ceric Sàrl
Active, not recruiting - verified May 2017

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Condition:   Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions:   Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
Sponsors:   AstraZeneca;   Cleveland Clinic Coordinating Center for Clinical Research (C5R);   Quintiles, Inc.
Active, not recruiting - verified May 2017

Drug Use Investigation for IMIGRAN Tablet

Condition:   Migraine Disorders
Intervention:   Drug: Sumatriptan
Sponsor:   GlaxoSmithKline
Completed - verified May 2017

Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy

Condition:   Dilated Cardiomyopathy
Interventions:   Device: protein A immunoadsorption;   Device: pseudo-immunoadsorption
Sponsors:   University Medicine Greifswald;   Krupp von Bohlen und Halbach-Foundation, Essen, Germany;   ENDI-Foundation, Bad Homburg, Germany;   Bristol-Myers Squibb
Recruiting - verified May 2017